Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1
Authors:
- Chengguo XingCXChengguo Xing
- Liangyou WangLWLiangyou Wang
- XiaoHu TangXTXiaoHu Tang
- Yuk Y. ShamYuk Y. Sham
- 1 March 2007
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (5) , 2167-2176
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- An inhibitor of Bcl-2 family proteins induces regression of solid tumoursNature, 2005
- Modulation of tamoxifen sensitivity by antisense Bcl‐2 and trastuzumab in breast carcinoma cellsCancer, 2005
- Breast Cancer Cells Can Evade Apoptosis-Mediated Selective Killing by a Novel Small Molecule Inhibitor of Bcl-2Cancer Research, 2004
- Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 HelixScience, 2004
- Structural biology of the Bcl-2 family of proteinsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2004
- Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cellsBiochemical and Biophysical Research Communications, 2004
- Angiogenesis and apoptosisSeminars in Cancer Biology, 2003
- Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer ScreeningJournal of Medicinal Chemistry, 2001
- Bcl-2 family proteinsOncogene, 1998
- Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of ApoptosisScience, 1997